查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1829744

2025年全球微创青光眼手术（MIGS）设备市场报告

Minimally Invasive Glaucoma Surgery (MIGS) Devices Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，微创青光眼手术 (MIGS) 设备的市场规模呈指数级增长，从 2024 年的 7 亿美元增长到 2025 年的 8.9 亿美元，复合年增长率为 27.6%。预测期内的增长可归因于人们预防失明意识的增强、医疗基础设施投资的增加、患者对先进视力治疗的认知度不断提高、公众对先进视力治疗的认知度不断提高以及政府倡议的不断加强。

微创青光眼手术 (MIGS) 设备市场规模预计将在未来几年呈指数级增长，到 2029 年将达到 22.9 亿美元，复合年增长率为 26.5%。预测期内的增长归因于青光眼等眼科疾病的盛行率不断上升、老年人口不断增长、医疗保健基础设施不断完善以及对更安全、更高效治疗的需求日益增长。预测期内的主要趋势包括 MIGS 设备的普及、技术进步、创新型微创青光眼手术设备的开发、先进植入式设备的开发以及眼科技术的进步。

微创青光眼手术 (MIGS) 设备是一种旨在降低青光眼患者眼压的医疗设备，其采用的侵入性比传统青光眼手术更小。 MIGS 旨在提供更安全、侵入性更低的青光眼手术选择，减少併发症，缩短恢復时间，并改善患者预后。

MIGS 装置的主要类型包括瓣膜、青光眼引流植入、青光眼管分流器和支架。青光眼引流植入，也称为房水分流器或管分流器，是透过手术植入眼内用于治疗青光眼的小型装置。这些装置可用于多种手术，包括青光眼手术合併白内障摘除术或单独的青光眼手术，其目标区域包括海绵状视网膜和脉络膜上腔。它们透过直销和零售等各种管道分销，并由眼科诊所和门诊手术中心 (ASC) 等终端用户使用。

2025年春季美国关税的突然上调及其引发的贸易摩擦对医疗设备行业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战使情况更加复杂，因为由于关税而更换供应商通常需要医疗设备重新认证，导致市场进入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司（The Business Research Company）新报告系列的一部分，该系列提供微创青光眼手术 (MIGS) 设备的市场统计数据，例如全球市场规模、区域份额、竞争对手的市场份额、详细的微创青光眼手术 (MIGS) 设备细分市场、市场趋势和商机，以及您在微创青光眼手术 (MIGS) 设备行业取得成功所需的数据。本微创青光眼手术 (MIGS) 设备研究报告对该行业的现状和未来趋势进行了详细分析，为您提供所需的一切观点。

我们预测未来五年该市场将成长26.5%，较先前预测略有下降1.6%。这一下降主要源于美国与其他国家之间关税的影响，这些关税导致以色列製造的微型支架供应链中断，从而直接影响美国，可能延误青光眼患者的治疗方案，并增加眼科手术费用。由于互惠关税以及贸易紧张局势和限制措施升级对全球经济和贸易的负面影响，其影响将更为广泛。

预计未来眼科疾病盛行率的上升将推动微创青光眼手术 (MIGS) 设备的成长。眼科疾病涵盖了影响眼睛和视力的多种疾病，由于生活方式的改变、环境因素和人口老化，其盛行率正在上升。 MIGS 设备是用于治疗各种眼科疾病的创新工具，主要透过降低眼压来预防或减缓青光眼的进展。例如，根据美国政府机构国家眼科研究所的数据，到 2030 年，约有 220 万美国将失明或部分失明。因此，眼科疾病盛行率的上升正在推动 MIGS 设备市场的发展。

MIGS 设备市场的主要企业正专注于开发创新产品，例如支架注射系统，以满足青光眼管理中尚未满足的需求并改善患者的治疗效果。支架注射系统是一种 MIGS 设备，它透过类似注射的程序将小型支架输送并植入体内，使用常用于微创手术治疗血管阻塞或狭窄等疾病的专用输送机制。例如，2022 年 8 月，美国眼科医疗技术公司 Glaucos Corporation 的 iStent Infinite 小梁微旁路系统获得了美国食品药物管理局(FDA) 的 510(k) 许可。 iStent Infinite 是一种新型三支架注射系统，旨在为无法透过药物或手术治疗控制眼压的原发性开放性青光眼(POAG) 患者提供全天候眼压控制的基础。

2024年7月，瑞士医疗设备製造商爱尔康以8,100万美元收购了贝尔金视力公司（Belkin Vision）。此次策略性收购旨在推广直接选择性雷射小梁成形术（DSLT）作为青光眼的第一线治疗方法，使其在全球普及。贝尔金视力公司是医疗设备製造商，专门研发和製造用于治疗青光眼的雷射治疗设备。

微创青光眼手术 (MIGS) 装置市场的主要参与者包括 AbbVie Inc.、Novartis AG、Alcon Inc.、Bausch Health Companies Inc.、Bausch & Lomb Incorporated Inc.、Carl Zeiss Meditec AG、Santen Pharmaceutical Co. Ltd.、Johnson & Johnson Vision Care Inc.、Lume Surm. Therapeutix Inc.、Iridex Corporation、Ellex Medical Lasers Ltd.、New World Medical Inc.、MicroSurgical Technology Inc.、Nova Eye Medical Limited、Asico LLC、Ziemer Ophthalmic Systems AG、Transcend Medical、iSTAR Medical SA、Ivantis Group Inc.、Allergan 和 InnFocus Inc.。

2024年，北美是微创青光眼手术 (MIGS) 设备市场最大的地区。预计亚太地区将成为预测期内成长最快的地区。微创青光眼手术 (MIGS) 设备市场报告涵盖亚太地区、西欧、中欧和东欧、北美、南美以及中东和非洲。

微创青光眼手术 (MIGS) 设备市场报告涵盖的国家有澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国、英国、美国、义大利和西班牙。

微创青光眼手术 (MIGS) 设备市场由提供以管道为基础的手术、内臟吻合术和小管成形术的营业单位所获得的收益所构成。市场价值包括服务供应商销售或包含在其服务产品中的相关产品的价值。 MIGS 设备市场还包括青光眼引流植入、青光眼管分流器和侵入性设备的销售。此市场价值为“出厂价”，即商品製造商或生产商销售给其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接销售给最终客户的商品价值。该市场中的商品价值也包括商品製造商销售的相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球微创青光眼手术 (MIGS) 设备：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球微创青光眼手术（MIGS）设备市场：成长率分析
  • 全球微创青光眼手术 (MIGS) 设备市场表现：规模与成长，2019-2024 年
  • 全球微创青光眼手术 (MIGS) 设备市场预测：规模与成长，2024-2029 年，2034 年
  • 全球微创青光眼手术 (MIGS) 设备：总目标市场 (TAM)

第六章 市场细分

  • 全球微创青光眼手术 (MIGS) 设备市场（按产品、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 阀门
  • 青光眼引流植入
  • 青光眼管分流术
  • 支架
  • 其他产品
  • 全球微创青光眼手术 (MIGS) 设备市场（按手术方式、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 青光眼伴白内障
  • 孤立性青光眼
  • 全球微创青光眼手术 (MIGS) 设备市场：按产品、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 小梁网
  • 脉络膜上腔
  • 其他科目
  • 全球微创青光眼手术 (MIGS) 设备市场（按分销管道、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 直接竞标
  • 零售
  • 全球微创青光眼手术 (MIGS) 设备市场（按最终用户、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 眼科诊所
  • 门诊手术中心（ASCS）
  • 其他最终用户
  • 全球微创青光眼手术 (MIGS) 设备市场：按瓣膜细分（按类型）、业绩及预测，2019-2024 年、2024-2029 年、2034 年
  • 微型分流阀
  • 非穿透阀
  • 全球微创青光眼手术 (MIGS) 装置市场：按青光眼引流植入细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 巩膜引流植入
  • 结膜下引流植入
  • 全球微创青光眼手术 (MIGS) 设备市场：按青光眼管分流器细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • Ahmed 管分流术
  • 瓣膜管分流术
  • 全球微创青光眼手术 (MIGS) 设备市场：按支架细分（按类型）、业绩及预测，2019-2024 年、2024-2029 年、2034 年
  • 眼内支架
  • 眼外支架
  • 全球微创青光眼手术 (MIGS) 设备市场：按产品类型、性能和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 循环破坏装置
  • 小梁旁路装置

第七章 区域和国家分析

  • 全球微创青光眼手术 (MIGS) 设备市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球微创青光眼手术 (MIGS) 设备市场：国家、绩效及预测（2019-2024 年、2024-2029 年、2034 年）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 微创青光眼手术（MIGS）设备市场：竞争格局
  • 微创青光眼手术（MIGS）设备市场：公司简介
    • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
    • Alcon Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Bausch Health Companies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Bausch & Lomb Incorporated Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Carl Zeiss Meditec AG
  • Santen Pharmaceutical Co. Ltd.
  • Johnson & Johnson Vision Care Inc.
  • Lumenis Ltd.
  • Staar Surgical Company
  • Glaukos Corporation
  • Sight Sciences Inc.
  • Ocular Therapeutix Inc.
  • Iridex Corporation
  • Ellex Medical Lasers Ltd.
  • New World Medical Inc
  • MicroSurgical Technology Inc.
  • Nova Eye Medical Limited
  • Asico LLC
  • Ziemer Ophthalmic Systems AG

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029年微创青光眼手术（MIGS）设备市场：提供新机会的国家
  • 2029年微创青光眼手术（MIGS）设备市场：细分市场带来新机会
  • 微创青光眼手术（MIGS）设备市场2029年：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r30703u

Minimally invasive glaucoma surgery (MIGS) devices are medical tools designed to lower intraocular pressure (IOP) in glaucoma patients using less invasive techniques compared to traditional glaucoma surgeries. These devices aim to reduce complications, shorten recovery times, and improve patient outcomes by providing a safer, less invasive surgical option for managing glaucoma.

The main types of MIGS devices include valves, glaucoma drainage implants, glaucoma tube shunts, stents, and others. A glaucoma drainage implant, also known as an aqueous shunt or tube shunt, is a small device surgically placed in the eye to treat glaucoma. These devices are used in various surgeries, such as those for glaucoma combined with cataracts or stand-alone glaucoma procedures, targeting areas such as the trabecular meshwork and suprachoroidal space. They are distributed through various channels, including direct tender and retail sales, and are utilized by end users such as ophthalmology clinics and ambulatory surgery centers (ASCs).

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The minimally invasive glaucoma surgery (MIGS) devices market research report is one of a series of new reports from The Business Research Company that provides minimally invasive glaucoma surgery (MIGS) devices market statistics, including minimally invasive glaucoma surgery (MIGS) devices industry global market size, regional shares, competitors with a minimally invasive glaucoma surgery (MIGS) devices market share, detailed minimally invasive glaucoma surgery (MIGS) devices market segments, market trends and opportunities, and any further data you may need to thrive in the minimally invasive glaucoma surgery (MIGS) devices industry. This minimally invasive glaucoma surgery (MIGS) devices research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The minimally invasive glaucoma surgery (migs) devices market size has grown exponentially in recent years. It will grow from $0.7 billion in 2024 to $0.89 billion in 2025 at a compound annual growth rate (CAGR) of 27.6%. The growth in the historic period can be attributed to increased awareness for the prevention of blindness, increased investments in healthcare infrastructure, increased patient awareness surrounding advanced corrective vision treatments, rise in awareness surrounding advanced corrective vision treatments, increased government initiatives.

The minimally invasive glaucoma surgery (migs) devices market size is expected to see exponential growth in the next few years. It will grow to $2.29 billion in 2029 at a compound annual growth rate (CAGR) of 26.5%. The growth in the forecast period can be attributed to increasing prevalence of eye disorders like glaucoma, rise in geriatric population, growing healthcare infrastructure, growing need for safer and more efficient treatment. Major trends in the forecast period include adoption of MIGS devices, advancements in technology, development of innovative minimally invasive glaucoma surgery devices, development of advanced implantable devices, advances in ophthalmic technology.

The forecast of 26.5% growth over the next five years reflects a modest reduction of 1.6% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for micro-stents manufactured in Israel, potentially delaying treatment options for glaucoma patients and increasing ophthalmic surgery costs.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of eye disorders is anticipated to drive the growth of minimally invasive glaucoma surgery (MIGS) devices in the future. Eye disorders cover a wide range of conditions affecting the eyes and vision, with their prevalence rising due to lifestyle changes, environmental factors, and aging populations. MIGS devices are innovative tools used to manage various eye diseases, primarily by reducing intraocular pressure (IOP) to prevent or control the progression of glaucoma. For example, according to the National Eye Institute, a US-based government agency, approximately 2.2 million Americans will be blind or partially blind by 2030. Consequently, the growing prevalence of eye disorders is propelling the MIGS devices market.

Leading companies in the MIGS devices market are focused on developing innovative products, such as stent injectable systems, to address unmet needs in glaucoma management and enhance patient outcomes. A stent injectable system is a MIGS device that delivers and implants a small stent into the body through an injection-like procedure, typically using a specialized delivery mechanism commonly employed in minimally invasive surgeries to treat conditions such as blocked or narrowed blood vessels. For instance, in August 2022, Glaukos Corporation, a US-based ophthalmic medical technology company, received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the iStent Infinite Trabecular Micro-Bypass System. The iStent Infinite is a novel three-stent injectable system designed to provide foundational, 24/7 IOP control for patients with primary open-angle glaucoma (POAG) whose IOP remains uncontrolled despite prior medication and surgical therapy.

In July 2024, Alcon Inc., a Switzerland-based medical device company, acquired BELKIN Vision Inc. for $81 million. This strategic acquisition is intended to boost the global adoption of Direct Selective Laser Trabeculoplasty (DSLT) as a first-line treatment for glaucoma. BELKIN Vision Inc., an Israel-based medical device company, specializes in developing and manufacturing laser therapy devices for glaucoma treatment.

Major companies operating in the minimally invasive glaucoma surgery (MIGS) devices market are AbbVie Inc., Novartis AG, Alcon Inc., Bausch Health Companies Inc., Bausch & Lomb Incorporated Inc., Carl Zeiss Meditec AG, Santen Pharmaceutical Co. Ltd., Johnson & Johnson Vision Care Inc., Lumenis Ltd., Staar Surgical Company, Glaukos Corporation, Sight Sciences Inc., Ocular Therapeutix Inc., Iridex Corporation, Ellex Medical Lasers Ltd., New World Medical Inc, MicroSurgical Technology Inc., Nova Eye Medical Limited, Asico LLC, Ziemer Ophthalmic Systems AG, Transcend Medical, iSTAR Medical SA, Ivantis Group Inc., Allergan, InnFocus Inc.

North America was the largest region in the minimally invasive glaucoma surgery (MIGS) devices market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the minimally invasive glaucoma surgery (MIGS) devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the minimally invasive glaucoma surgery (MIGS) devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The minimally invasive glaucoma surgery (MIGS) devices market consists of revenues earned by entities by providing canal-based procedures, viscocanalostomy, and canaloplasty procedures. The market value includes the value of related goods sold by the service provider or included within the service offering. The minimally invasive glaucoma surgery (MIGS) devices market also includes sales of glaucoma drainage implants, glaucoma tube shunts, and invasive devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Minimally Invasive Glaucoma Surgery (MIGS) Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on minimally invasive glaucoma surgery (migs) devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for minimally invasive glaucoma surgery (migs) devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The minimally invasive glaucoma surgery (migs) devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Valves; Glaucoma Drainage Implant; Glaucoma Tube Shunts; Stents; Other Products
  • 2) By Surgery: Glaucoma In Conjunction With Cataract; Stand Alone Glaucoma
  • 3) By Target: Trabecular Meshwork; Suprachoroidal Space; Other Targets
  • 4) By Distribution Channel: Direct Tender; Retail Sales
  • 5) By End User: Ophthalmology Clinics; Ambulatory Surgery Centers (ASCS); Other End Users
  • Subsegments:
  • 1) By Valves: Micro Shunt Valves; Non-penetrating Valves
  • 2) By Glaucoma Drainage Implant: Scleral Drainage Implants; Subconjunctival Drainage Implants
  • 3) By Glaucoma Tube Shunts: Ahmed Tube Shunt; Baerveldt Tube Shunt
  • 4) By Stents: Ab-Interno Stents; Ab-Externo Stents
  • 5) By Other Products: Cyclodestructive Devices; Trabecular Bypass Devices
  • Companies Mentioned: AbbVie Inc.; Novartis AG; Alcon Inc.; Bausch Health Companies Inc.; Bausch & Lomb Incorporated Inc.; Carl Zeiss Meditec AG; Santen Pharmaceutical Co. Ltd.; Johnson & Johnson Vision Care Inc.; Lumenis Ltd.; Staar Surgical Company; Glaukos Corporation; Sight Sciences Inc.; Ocular Therapeutix Inc.; Iridex Corporation; Ellex Medical Lasers Ltd.; New World Medical Inc; MicroSurgical Technology Inc.; Nova Eye Medical Limited; Asico LLC; Ziemer Ophthalmic Systems AG; Transcend Medical; iSTAR Medical SA; Ivantis Group Inc.; Allergan; InnFocus Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Characteristics

3. Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Trends And Strategies

4. Minimally Invasive Glaucoma Surgery (MIGS) Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Growth Rate Analysis
  • 5.4. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Total Addressable Market (TAM)

6. Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Segmentation

  • 6.1. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Valves
  • Glaucoma Drainage Implant
  • Glaucoma Tube Shunts
  • Stents
  • Other Products
  • 6.2. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Glaucoma In Conjunction With Cataract
  • Stand Alone Glaucoma
  • 6.3. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Trabecular Meshwork
  • Suprachoroidal Space
  • Other Targets
  • 6.4. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Direct Tender
  • Retail Sales
  • 6.5. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Ophthalmology Clinics
  • Ambulatory Surgery Centers (ASCS)
  • Other End Users
  • 6.6. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Sub-Segmentation Of Valves, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Micro Shunt Valves
  • Non-penetrating Valves
  • 6.7. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Sub-Segmentation Of Glaucoma Drainage Implant, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Scleral Drainage Implants
  • Subconjunctival Drainage Implants
  • 6.8. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Sub-Segmentation Of Glaucoma Tube Shunts, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Ahmed Tube Shunt
  • Baerveldt Tube Shunt
  • 6.9. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Sub-Segmentation Of Stents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Ab-Interno Stents
  • Ab-Externo Stents
  • 6.10. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cyclodestructive Devices
  • Trabecular Bypass Devices

7. Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Regional And Country Analysis

  • 7.1. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

  • 8.1. Asia-Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

  • 9.1. China Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Overview
  • 9.2. China Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

  • 10.1. India Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

  • 11.1. Japan Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Overview
  • 11.2. Japan Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

  • 12.1. Australia Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

  • 13.1. Indonesia Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

  • 14.1. South Korea Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Overview
  • 14.2. South Korea Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

  • 15.1. Western Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Overview
  • 15.2. Western Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

  • 16.1. UK Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

  • 17.1. Germany Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

  • 18.1. France Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

  • 19.1. Italy Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

  • 20.1. Spain Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

  • 21.1. Eastern Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Overview
  • 21.2. Eastern Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

  • 22.1. Russia Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

  • 23.1. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Overview
  • 23.2. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

  • 24.1. USA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Overview
  • 24.2. USA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

  • 25.1. Canada Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Overview
  • 25.2. Canada Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

  • 26.1. South America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Overview
  • 26.2. South America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

  • 27.1. Brazil Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

  • 28.1. Middle East Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Overview
  • 28.2. Middle East Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

  • 29.1. Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Overview
  • 29.2. Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Surgery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, Segmentation By Target, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Competitive Landscape And Company Profiles

  • 30.1. Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Competitive Landscape
  • 30.2. Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Company Profiles
    • 30.2.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Alcon Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Bausch Health Companies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Bausch & Lomb Incorporated Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Other Major And Innovative Companies

  • 31.1. Carl Zeiss Meditec AG
  • 31.2. Santen Pharmaceutical Co. Ltd.
  • 31.3. Johnson & Johnson Vision Care Inc.
  • 31.4. Lumenis Ltd.
  • 31.5. Staar Surgical Company
  • 31.6. Glaukos Corporation
  • 31.7. Sight Sciences Inc.
  • 31.8. Ocular Therapeutix Inc.
  • 31.9. Iridex Corporation
  • 31.10. Ellex Medical Lasers Ltd.
  • 31.11. New World Medical Inc
  • 31.12. MicroSurgical Technology Inc.
  • 31.13. Nova Eye Medical Limited
  • 31.14. Asico LLC
  • 31.15. Ziemer Ophthalmic Systems AG

32. Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

34. Recent Developments In The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market

35. Minimally Invasive Glaucoma Surgery (MIGS) Devices Market High Potential Countries, Segments and Strategies

  • 35.1 Minimally Invasive Glaucoma Surgery (MIGS) Devices Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Minimally Invasive Glaucoma Surgery (MIGS) Devices Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Minimally Invasive Glaucoma Surgery (MIGS) Devices Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer